GLP-1 agonists associated with lower stroke risk in patients with type 2 diabetes at high risk for cardiovascular disease

GLP-1 agonists associated with lower stroke risk in patients with type 2 diabetes at high risk for cardiovascular disease is a topic covered in the EE+ POEM Archive.

To view the entire topic, please log in or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics: